New Genetic Test and Surgery for Inherited Thyroid Garcinoma and Breast Cancer
New Genetic Test and Surgery for Inherited Thyroid Garcinoma and Breast Cancer
批准号:
14571158
负责人:
TAKAMI Hiroshi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background : Medullary thyroid carcinoma (MTC) is a sporadic and inherited disease with multiple endocrine neoplasia (MEN), type 2A; MEN, type 2B; familial non-MEN medullary carcinoma (FMTC) ; as features of the inherited type. The inherited forms are autosomal dominant traits, associated with germline mutations of the RET protooncogene. Determination of stimulated levels of serum calcitonin is a sensitive and specific marker for medullary thyroid carcinoma. Genetic testing identifies carriers of the mutant gene and allows preventive thyroidectomy in such individuals.Methods : A large scale nationwide questionnaire survey was conducted in 1996 and again in 2002. This is a report of the two surveys that characterizes the clinical course of the inherited form of MTC, as determined by the two surveys.Results : Among 634 cases in 1996, 175 (27.6%) were MEN2A ; 49 (7.7%), FMTC ; 20, MEN2B ; and 390, sporadic MTC. The overall male to female ratio was 1:2.5 ; 1:1.7 in MEN2A patients ; 1:2.3 i … More n FMTC patients ; 1:0.9 in EN2B patients ; and 1:3.3 in patients with sporadic MTC. The mean age, at the time of diagnosis, was 40.3 years in MEN2A patients, 43.6 years in FMTC patients, 26.5 years in MEN2B patients, and 48.5 years in patients with sporadic MTC. The most common finding that led to the clinical diagnosis of familial MTC was a mass in the neck. From the survey of 2002, among the 271 patients, 83 (30.6%) had MEN2A ; 14 (5.1%), FMTC ; 11(4.1%), MEN2B ; and 163 60.1%), sporadic MTC. The male to female ratio was 1:1.8 overall ; 1:1.4, in MEN2A patients ; 1:0.8 in FMTC patients ; 1:1.8 in the MEN 2B patients ; and 1:2.3 in the patients with sporadic MTC. Mean age was 35,6 years in MEN2A patients ; 34.6 years in MEN2A patients ; 30.5 years in MEN2B patients ; and 47.6 years in patients with sporadic MTC. The most common clinical finding that led to the diagnosis was the detection of a RET mutation. The overall 5-year survival rates were : MEN 2A, 96.9% ; FMTC, 100% ; MEN2B, 73.8% ; and sporadic MTC, 90.8%.Conclusions :1) MEN2A was the most common inherited type of MTC in these surveys, followed by FMTC and MEN2B. 2) The male to female ratio did not substantially differ in the two surveys, although the ratios in the familial and sporadic MTC showed a tendency to decrease. 3) The age at the time of diagnosis decreased in all four categories between the two surveys, 10. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takami, H., Ikeda, Y., Okinaga, W., Kameyama, K.: "Review : Recent adcances in the management of primary hyperathyroidism"Endocrine Journal. 50(4). 369-377 (2003)
Takami, H.、Ikeda, Y.、Okinaga, W.、Kameyama, K.:“综述:原发性甲状旁腺功能亢进治疗的最新进展”内分泌杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takami, H.: "Medullary thyroid carcinoma and multiple endocrine neoplasia type 2"Endocrine Pathology. 14(2). 123-132 (2003)
Takami, H.:“甲状腺髓样癌和多发性内分泌肿瘤 2 型”内分泌病理学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takami, H.: "Medullary thyroid carcinoma and multiple endocrine neoplasia type 2"Endocrine pathology. 14. 123-132 (2003)
Takami, H.:“甲状腺髓样癌和多发性内分泌肿瘤 2 型”内分泌病理学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takami, H.: "Review : Recent adcances in the management of primary hyperparathyroidism"Endcrine Journal. 50. 369-377 (2003)
Takami, H.:“综述:原发性甲状旁腺功能亢进治疗的最新进展”内分泌杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroshi Takami: "Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2"Endocrine Pathology. Vol.14 No.2. 123-131 (2003)
Hiroshi Takami:“甲状腺髓样癌和多发性内分泌肿瘤2型”内分泌病理学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Development of minimally invasive thyroid and parathyroid surgery
-
批准号:16591273
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:TAKAMI Hiroshi
-
依托单位:
Genetic Diagnosis and Prophylactic Surgery for Inherited Medullary Thyroid Carcinoma
-
批准号:11671184
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1999
-
负责人:TAKAMI Hiroshi
-
依托单位:
Development of rasonable parathyroidectomy employing intraoperative gamma probe
-
批准号:09671252
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:TAKAMI Hiroshi
-
依托单位:
Mutation of RET proto-oncogene in Families of multiple endocrine neoplasia type 2
-
批准号:07671332
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:TAKAMI Hiroshi
-
依托单位:
A study on new diagnosis and treatment by receptorscintigraphy for neuroendocrine tumor
-
批准号:05671027
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1993
-
负责人:TAKAMI Hiroshi
-
依托单位:
Targeting therapy against neuroendocrine tumor employing anticalcitonin gene antibody
-
批准号:03670599
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1991
-
负责人:TAKAMI Hiroshi
-
依托单位:
Experimental study on intraoperative diagnosis of metastatic region
-
批准号:63570649
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1988
-
负责人:TAKAMI Hiroshi
-
依托单位:
海外基金